Skip to main content
logo
Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.315
-0.335 (-20.30%)
Nov 6, 2026, 12:32 PM EST - Market open

Serina Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.130.063.150.593.46
Revenue Growth
-132.14%-98.22%433.05%-82.93%-
Gross Profit
-14.07-13.03-7.420.77-0.98-0.33
Operating Income
-25.66-24.02-15.57-1.53-2.27-1.63
Net Income
-23.93-19.44-11.145.27-2.68-1.26
Earnings Per Share
-1.93-1.91-1.510.72-1.25-0.59
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
23.023.063.677.620.531.31
Total Debt
3.753.320.273.71.810.4
Net Cash (Debt)
19.27-0.273.43.92-1.280.91
Net Cash Growth
239.32%--13.25%---
Net Cash Per Share
1.56-0.030.460.53-0.600.43

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.14-17.96-17.14-2.48-2.08-2.25
Capital Expenditures
-0.07-0.06-0.02-0.5-0.01-0.08
Free Cash Flow
-21.2-18.01-17.16-2.98-2.09-2.34
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---24.26%-165.95%-9.63%
Operating Margin
--18478.46%-27807.14%-48.52%-383.83%-47.09%
Pretax Margin
--14766.92%-20012.50%167.11%-453.44%-36.50%
Profit Margin
--14950.77%-19894.64%167.11%-453.44%-36.50%
FCF Margin
--13856.92%-30641.07%-94.51%-352.55%-67.41%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-156.93840.25---